Supplemental material
Hematology
Volume 24, 2019 - Issue 1
Articles
Therapeutic options for adult patients with previously treated immune thrombocytopenia – a systematic review and network meta-analysis
Ran YangDepartment of Hematology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China
https://orcid.org/0000-0002-1097-3573View further author information
https://orcid.org/0000-0002-1097-3573View further author information, , , & Related Research Data
UPDATE ON ROMIPLOSTIM AND ELTROMBOPAG INDIRECT COMPARISON
Source:
Cambridge University Press (CUP)
A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia
Source:
Springer Nature
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia
Source:
American Society of Hematology
Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia
Source:
Wiley-Blackwell
Morbidity and mortality in adults with idiopathic thrombocytopenic purpura
Source:
American Society of Hematology
Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura
Source:
New England Journal of Medicine (NEJM/MMS)
A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia
Source:
American Society of Hematology
A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP
Source:
American Society of Hematology
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.
Source:
American Society of Hematology
The Bleeding Risk and Natural History of Idiopathic Thrombocytopenic Purpura in Patients With Persistent Low Platelet Counts
Source:
American Medical Association (AMA)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
Source:
Elsevier BV
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials
Source:
Elsevier BV
Fostamatinib for persistent/chronic adult immune thrombocytopenia
Source:
Future Medicine Ltd
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Source:
American Society of Hematology
Thrombopoietin receptor agonists shift the balance of Fcγ receptors toward inhibitory receptor IIb on monocytes in ITP
Source:
American Society of Hematology
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.
Source:
Massachusetts Medical Society
Comparison of up-front treatments for newly diagnosed immune thrombocytopenia -a systematic review and network meta-analysis
Source:
Ferrata Storti Foundation (Haematologica)
Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia
Source:
Springer Nature
Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk
Source:
American Society of Hematology
Therapeutic options for adult patients with previously treated immune thrombocytopenia – a systematic review and network meta-analysis
Source:
Taylor & Francis
Systematic review : Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura
Source:
American College of Physicians
International consensus report on the investigation and management of primary immune thrombocytopenia.
Source:
American Society of Hematology
Therapeutic options for adult patients with previously treated immune thrombocytopenia – a systematic review and network meta-analysis
Source:
Taylor & Francis
Management of Adult Idiopathic Thrombocytopenic Purpura
Source:
Annual Reviews
Eltrombopag versus romiplostim in treatment of adult patients with immune thrombocytopenia: A systematic review incorporating an indirect-comparison meta-analysis
Source:
Public Library of Science (PLoS)
Linking provided by
